Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Horizon Pharma USA Inc.

Division of Horizon Therapeutics PLC
www.horizontherapeutics.com

Latest From Horizon Pharma USA Inc.

Dr Reddy’s Debuts US Vimovo Rival At Risk

Dr Reddy’s has announced the launch of the first US generic version of Vimovo delayed-release tablets. However, Nuvo has warned that the at-risk launch infringes patents protecting the arthritis pain treatment until May 2022.

Launches Generic Drugs

Actavis Faces Wait Until 2027 On US Pennsaid

Teva’s Actavis has lost the patent battle over osteoarthritis drug Pennsaid 2% due to a lack of “clear and convincing evidence” and “unpersuasive arguments” over obviousness.

Intellectual Property Generic Drugs

Finance Watch: Genmab Launches This Year's Biggest Biopharma IPO In The US

Public Company Edition: Genmab raised $505.9m while other 17 July IPOs from Fulcrum and Mirum grossed $72m and $75m, respectively. Also, Horizon sells notes to pay down debt and Inovio reduces its workforce by 28%.

Business Strategies Financing

US Product Launches To Plan For In 2020

A sizeable group of key late-stage products have the potential to reach the US market in 2020, according to a recent report from Informa’s Biomedtracker. Pharmaceutical and biotech executives will have to be on their A-game to integrate the new wave of products into patient-centric and market access-friendly commercial strategies.

Approvals Market Intelligence
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Gastrointestinal
  • Inflammation
  • Neurology, Nervous System
  • Alias(es)
  • Horizon Therapeutics Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Horizon Therapeutics PLC
  • Senior Management
  • Timonthy P Walbert, Pres. & CEO
    Robert J. De Vaere, EVP, CFO
    Jeffrey W Sherman, MD, EVP, Dev., Reg. Affairs & CMO
    Joe Whalen, VP, Bus. Dev. & Licensing
  • Contact Info
  • Horizon Pharma USA Inc.
    Phone: (224) 383-3000
    1033 Skokie Blvd.
    Ste. 355
    Northbrook, IL 60062
    USA
UsernamePublicRestriction

Register